2-Year U.S. Treasury Note Continuous Contract $104.125 0.031 0.03% 5-Year U.S. Treasury Note Continuous Contract $109.234 0.063 0.06% 10-Year U.S. Treasury Note Continuous Contract $112.719 0.078 0.07 ...
The FDA's interactions with Biogen in the build-up to last year's controversial approval of Alzheimer's disease therapy Aduhelm have been described as "inappropriate" and "atypical" in a congressional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback